Which tests measure Potassium, Serum?

Potassium, Serum is measured in 1 test on BiomarkersLabs.com, including Potassium, Serum.

Biomarker Reference · K⁺

What does the Potassium, Serum test measure?

Q: Why is Potassium, Serum measured?

Serum potassium is one of the highest-stakes electrolyte measurements in clinical practice, with deviations in either direction carrying significant cardiac arrhythmia risk. Hypokalaemia — serum potassium below 3.5 mEq/L — hyperpolarises cell membranes, reducing excitability and predisposing to ventricular ectopy, torsades de pointes, and life-threatening ventricular fibrillation, particularly in patients with underlying cardiac disease, digoxin use, or QT prolongation. Hyperkalaemia — serum potassium above 5.1 mEq/L — depolarises cell membranes, impairing cardiac conduction and producing the characteristic ECG progression of peaked T waves, widened QRS, sine wave pattern, and ventricular fibrillation or asystole at severe levels. Serum potassium is the mandatory monitoring marker for a wide array of medications that alter potassium homeostasis — diuretics, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, digoxin, and immunosuppressants — and is a core component of renal function assessment, adrenal disease evaluation, and acid-base disorder characterisation. Pre-analytical integrity is the dominant clinical challenge — haemolysis from any cause elevates serum potassium artifactually (pseudohyperkalaemia), and this is the single most important interpretive caveat for any elevated potassium result.

Q: What is the reference range for Potassium, Serum?

The standard reference range for Potassium, Serum is 3.5–5.1 mEq/L (3.5–5.1 mmol/L) # REVIEWER FLAG: Confirm Access Medical Laboratories reference range for serum potassium — upper and lower limits vary slightly between laboratories (some use 3.5–5.0, others 3.5–5.3 mEq/L). Confirm whether Access Medical Laboratories applies age-stratified reference intervals — serum potassium is modestly higher in neonates and infants. Confirm critical value thresholds flagged on Access Medical Laboratories reports — most laboratories flag <2.5 mEq/L and ≥6.0–6.5 mEq/L as critical values requiring urgent clinical notification.. Reference ranges vary by laboratory and assay platform — interpret in context of the issuing laboratory's stated range.

Potassium, Serum (K⁺) is a clinical biomarker used in metabolic-diabetes assessment. Potassium is the principal intracellular cation — approximately 98% of total body potassium (approximately 3,500 mEq in a 70 kg adult) is contained within cells, maintained by the ubiquitous Na⁺/K⁺-ATPase pump at an intracellular concentration of approximately 140–150 mEq/L. It is measured in 1 laboratory test on BiomarkersLabs.com.

Reference Range: 3.5–5.1 mEq/L (3.5–5.1 mmol/L) # REVIEWER FLAG: Confirm Access Medical Laboratories reference range for serum potassium — upper and lower limits vary slightly between laboratories (some use 3.5–5.0, others 3.5–5.3 mEq/L). Confirm whether Access Medical Laboratories applies age-stratified reference intervals — serum potassium is modestly higher in neonates and infants. Confirm critical value thresholds flagged on Access Medical Laboratories reports — most laboratories flag <2.5 mEq/L and ≥6.0–6.5 mEq/L as critical values requiring urgent clinical notification.
Units: mEq/L, mmol/L
Measured In: 1 test
Category: Metabolic

Functional medicine optimal3.8–4.5 mEq/L (functional medicine and cardiology optimal — this range is associated with the lowest risk of cardiac arrhythmia and all-cause mortality in population data; the lower end of the reference range [3.5–3.8 mEq/L] carries measurably increased cardiac event risk in patients with structural heart disease, digoxin use, or QT prolongation). # REVIEWER FLAG: The 3.8–4.5 mEq/L optimal is used in preventive cardiology and integrative practice but is not a universally standardised clinical guideline threshold — reviewer to confirm appropriate framing and whether cardiovascular outcome literature should be cited to support this range.

What is Potassium, Serum?

Potassium is the principal intracellular cation — approximately 98% of total body potassium (approximately 3,500 mEq in a 70 kg adult) is contained within cells, maintained by the ubiquitous Na⁺/K⁺-ATPase pump at an intracellular concentration of approximately 140–150 mEq/L. Serum potassium reflects only the extracellular pool — approximately 2% of total body potassium — and is maintained within a remarkably narrow physiological range (3.5–5.1 mEq/L) through the integrated actions of renal potassium handling, aldosterone, insulin, catecholamines, and acid-base status. Aldosterone is the primary regulator of renal potassium excretion — acting on principal cells of the cortical collecting duct to upregulate luminal ENaC sodium channels and ROMK potassium channels, driving sodium reabsorption and potassium excretion coupled to the electrochemical gradient. Insulin and beta-2 adrenergic agonists promote cellular potassium uptake by stimulating Na⁺/K⁺-ATPase activity; acidaemia drives potassium out of cells in exchange for hydrogen ions, raising serum potassium; alkalaemia reverses this shift, lowering serum potassium. The resting membrane potential of excitable cells — cardiac myocytes and neurones — is determined by the ratio of intracellular to extracellular potassium, making serum potassium the dominant determinant of cardiac rhythm and neuromuscular function.

Why is Potassium, Serum measured?

Serum potassium is one of the highest-stakes electrolyte measurements in clinical practice, with deviations in either direction carrying significant cardiac arrhythmia risk. Hypokalaemia — serum potassium below 3.5 mEq/L — hyperpolarises cell membranes, reducing excitability and predisposing to ventricular ectopy, torsades de pointes, and life-threatening ventricular fibrillation, particularly in patients with underlying cardiac disease, digoxin use, or QT prolongation. Hyperkalaemia — serum potassium above 5.1 mEq/L — depolarises cell membranes, impairing cardiac conduction and producing the characteristic ECG progression of peaked T waves, widened QRS, sine wave pattern, and ventricular fibrillation or asystole at severe levels. Serum potassium is the mandatory monitoring marker for a wide array of medications that alter potassium homeostasis — diuretics, ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, digoxin, and immunosuppressants — and is a core component of renal function assessment, adrenal disease evaluation, and acid-base disorder characterisation. Pre-analytical integrity is the dominant clinical challenge — haemolysis from any cause elevates serum potassium artifactually (pseudohyperkalaemia), and this is the single most important interpretive caveat for any elevated potassium result.

Reference ranges

Standard reference: 3.5–5.1 mEq/L (3.5–5.1 mmol/L) # REVIEWER FLAG: Confirm Access Medical Laboratories reference range for serum potassium — upper and lower limits vary slightly between laboratories (some use 3.5–5.0, others 3.5–5.3 mEq/L). Confirm whether Access Medical Laboratories applies age-stratified reference intervals — serum potassium is modestly higher in neonates and infants. Confirm critical value thresholds flagged on Access Medical Laboratories reports — most laboratories flag <2.5 mEq/L and ≥6.0–6.5 mEq/L as critical values requiring urgent clinical notification.
Functional medicine optimal: 3.8–4.5 mEq/L (functional medicine and cardiology optimal — this range is associated with the lowest risk of cardiac arrhythmia and all-cause mortality in population data; the lower end of the reference range [3.5–3.8 mEq/L] carries measurably increased cardiac event risk in patients with structural heart disease, digoxin use, or QT prolongation). # REVIEWER FLAG: The 3.8–4.5 mEq/L optimal is used in preventive cardiology and integrative practice but is not a universally standardised clinical guideline threshold — reviewer to confirm appropriate framing and whether cardiovascular outcome literature should be cited to support this range.
Units: mEq/L, mmol/L

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.

Tests that measure Potassium, Serum

1 test on BiomarkersLabs.com include this biomarker.

BML-MET-010Comprehensive

Potassium, Serum

Potassium, Serum reference range in this test: 3.5–5.1 mEq/L (3.5–5.1 mmol/L) # REVIEWER FLAG: Confirm Access Medical Laboratories reference range for serum potassium — upper and lower limits vary slightly between laboratories (some use 3.5–5.0, others 3.5–5.3 mEq/L). Confirm whether Access Medical Laboratories applies age-stratified reference intervals — serum potassium is modestly higher in neonates and infants. Confirm critical value thresholds flagged on Access Medical Laboratories reports — most laboratories flag <2.5 mEq/L and ≥6.0–6.5 mEq/L as critical values requiring urgent clinical notification.

Related clinical conditions

Order tests measuring Potassium, Serum for your patients

Available exclusively to verified licensed healthcare practitioners. CLIA-certified laboratory results delivered to your secure portal.